Filing Details
- Accession Number:
- 0001209191-11-036876
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2011-06-30 14:18:30
- Reporting Period:
- 2011-06-29
- Filing Date:
- 2011-06-30
- Accepted Time:
- 2011-06-30 14:18:30
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 875320 | Vertex Pharmaceuticals Inc / Ma | VRTX | Pharmaceutical Preparations (2834) | 043039129 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1046336 | S Kenneth Boger | C/O Vertex Pharmaceuticals Incorporated 130 Waverly St Cambridge MA 02176 | Svp & General Counsel | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2011-06-29 | 7,334 | $18.75 | 120,333 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2011-06-29 | 1,876 | $50.64 | 118,457 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2011-06-29 | 5,458 | $51.63 | 112,999 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option | Disposition | 2011-06-29 | 7,334 | $0.00 | 7,334 | $18.75 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 51,334 | 2011-09-23 | No | 4 | M | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 5,021 | Indirect | 401(k) |
| Common Stock | 174,167 | Indirect | Trustee of Trusts |
Footnotes
- Transaction made pursuant to Mr. Boger's company approved trading plan under Rule 10b5-1.
- Open market sales reported on this line occurred at a weighted average price of $50.64 (range $50.37 to $50.94).
- Mr. Boger undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.
- Open market sales reported on this line occurred at a weighted average price of $51.63 (range $51.02 to $51.88).
- Kenneth S. Boger is the trustee for trusts established for the benefit of the three adult children of Joshua S. Boger (a director of the issuer).
- Fully vested.
Billionaire Hedge Funds
